2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1831651868 MD
Verify on CMS →

MARK LARSON, MD

Glaucoma Specialist (Ophthalmology) Physician in GREENFIELD, Wisconsin. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
850
Medicare Part D claims · 253 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
58%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
85.2409/100
▲ 2 pts above national avg 83.1 · [object Object]
Industry payments
$288.25
7 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK LARSON, MD reported a CMS MIPS final score of 85.2409/100 — above the 83.1 national average — and filed 850 Medicare Part D claims in 2023.

85.2409/100
MIPS score · +2 vs avg
850
Part D claims, 2023
58%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK LARSON, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

85 49th percentile higher than 49% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK LARSON, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK LARSON, MD?

High performer (top quartile)

NPI registry status

Active

Issued 03/31/2019

NPI 1831651868

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

850 71% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

MIPS final score

85.2409/100 2.140900000000002% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Wisconsin

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Wisconsin providers

Wisconsin providers

Glaucoma Specialist (Ophthalmology) Physician share within Wisconsin

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within Wisconsin

Medicare quality performance — MIPS

MARK LARSON, MD's 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
85.2409/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 85.2409/100 vs national avg 83.1

0%100%National avg83%85.2%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 85.2409/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK LARSON, MD is a Glaucoma Specialist (Ophthalmology) Physician provider practicing in GREENFIELD, Wisconsin, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1831651868. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK LARSON, MD appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding MD credentials at 4600 W LOOMIS RD STE 310, GREENFIELD, WI, 53220, with a listed phone of (414) 281-0424. NPI 1831651868 was issued on 03/31/2019. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LARSON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 850 prescription claims written by this provider, covering 253 Medicare beneficiaries and totaling roughly $77K in drug spend, split 42% brand-name and 58% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 85.2409/100 for the 2023 performance year (Quality 97.9147, Cost 52.8883), compared with the national average of 83.1.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4600 W LOOMIS RD STE 310
GREENFIELD, WI 53220

Provider Details

NPI 1831651868
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials MD
Gender Male
NPI Issued 03/31/2019

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

85.2409
Final Score
Avg: 83.1
97.9147
Quality
52.8883
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK LARSON, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

OPHTHALMOLOGY ASSOCIATES S C
GREENFIELD, WI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK LARSON, MD. Source: openpaymentsdata.cms.gov.

Total received

$288

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

MARK LARSON, MD — brand share 42.0%
Specialty average (est.)

42% brand-name claims vs 58% generic, on 850 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

850
Total Claims
$77K
Total Drug Cost
253
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,212
Total Day Supply
32,202
Brand vs Generic
42% brand / 58% generic
Brand Drug Cost
$59K
Generic Drug Cost
$19K

Patient Demographics

Average Patient Age
71.9 years
Avg HCC Risk Score
1.64
Gender Split
53% female / 47% male
Age Distribution
<65: 39, 65-74: 117, 75-84: 72, 85+: 25

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
235
Prednisolone Acetate
126
Ketorolac Tromethamine
51
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
50
Ofloxacin
47
Brimonidine Tartrate
44
Timolol Maleate
43
Moxifloxacin
Moxifloxacin Hcl
27
Erythromycin
Erythromycin Base
25
Gatifloxacin
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How MARK LARSON, MD fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

MARK LARSON, MD's 850 claims are below the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Wisconsin

Other clinicians with the same primary specialty enrolled in Wisconsin, drawn from the same CMS NPPES roster as LARSON.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK LARSON, MD's specialty?
MARK LARSON, MD specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in GREENFIELD, Wisconsin. Credentials: MD.
How much does MARK LARSON, MD prescribe under Medicare Part D?
In 2023, MARK LARSON, MD wrote 850 Medicare Part D claims totaling $77K in drug costs for 253 beneficiaries.
What is MARK LARSON, MD's Medicare quality score?
MARK LARSON, MD has a CMS MIPS Final Score of 85.2409/100 (Quality: 97.9147, Cost: 52.8883). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK LARSON, MD located?
MARK LARSON, MD is located at 4600 W LOOMIS RD STE 310, GREENFIELD, WI, 53220. Phone: (414) 281-0424.
What is MARK LARSON, MD's NPI number?
MARK LARSON, MD's National Provider Identifier (NPI) is 1831651868, issued on 03/31/2019.
Does MARK LARSON, MD prescribe more brand-name or generic drugs?
MARK LARSON, MD's prescribing is 42% brand-name and 58% generic drugs by claim count, with $59K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does MARK LARSON, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK LARSON, MD's most frequently prescribed drugs include Latanoprost, Prednisolone Acetate, Ketorolac Tromethamine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK LARSON, MD accept Medicare?
MARK LARSON, MD appears in CMS Medicare data with 850 Part D claims and 253 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK LARSON, MD's credentials?
MARK LARSON, MD's NPI is 1831651868 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology